BNTC Stock Price | Benitec Biopharma Inc. P/E, Revenue, EPS, & Forecasts

Benitec Biopharma Inc. • BNTC

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Benitec Biopharma Inc.

Ticker

BNTC

Trading on

NASDAQ

ISIN

Industry

Biotechnology

Sector

Healthcare

CEO

Headquarters

3940 Trust Way, Hayward, CA, United States, 94545

Employees

Website

https://benitec.com

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines in the United States. Its Silence and Replace, a DNA-directedRNA interference platform, that combines RNA interference with gene therapy to create medicines which simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene, which is in phase 1b/2a for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.

Metrics

BasicAdvanced

Market cap

$297M

P/E ratio

EPS

-$0.98

Dividend Yield

0.00%

Beta

0.25

Forward P/E ratio

EBIDTA

$-51.1M

Ex dividend date

Price & volume

Market cap

$297M

Average daily volume

0.2M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

2,770.13

Price to book

1.94

Earnings

EPS

-$0.98

EPS estimate (current quarter)

-$0.27

EPS estimate (next quarter)

-$0.28

EBITDA

$-51.1M

Revenues (TTM)

$0M

Revenues per share (TTM)

$0.00

Technicals

Beta

0.25

52-week High

$16.76

52-week Low

$8.00

50-day moving average

$10.96

200-day moving average

$11.66

Short ratio

13.26

Short %

10.23%

Management effectiveness

ROE (TTM)

-33.21%

ROA (TTM)

-22.67%

Profit margin

0.00%

Gross profit margin

$0M

Operating margin

0.00%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

12.50%

Share stats

Outstanding Shares

34.9M

Float

18.5M

Insiders %

0.24%

Institutions %

96.04%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 7 analysts.

Average price target

$24.33

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.22

-$76.32

99.71%

Q3 • 25Beat

-$0.26

-$0.23

-13.04%

Q4 • 25Missed

-$0.24

-$0.28

14.29%

Q1 • 26Beat

-$0.26

Q2 • 26Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0M

$-11.9M

-∞%

Q1 • 26

$-0.8M

$-12.8M

1,537.61%

Q2 • 26

-∞%

7.32%

NaN%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$187M

$3.7M

1.96%

Q1 • 26

$183M

$5.6M

3.07%

Q2 • 26

-2.34%

52.94%

56.61%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-4.9M

$4.4M

$-4.9M

Q1 • 26

$-4.9M

$0.2M

$-5M

Q2 • 26

0.55%

-94.47%

1.83%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Benitec Biopharma Inc. share?

Benitec Biopharma Inc. shares are currently traded for undefined per share.

How many shares does Benitec Biopharma Inc. have?

Benitec Biopharma Inc. currently has 34.9M shares.

Does Benitec Biopharma Inc. pay dividends?

No, Benitec Biopharma Inc. doesn't pay dividends.

What is Benitec Biopharma Inc. 52 week high?

Benitec Biopharma Inc. 52 week high is $16.76.

What is Benitec Biopharma Inc. 52 week low?

Benitec Biopharma Inc. 52 week low is $8.00.

What is the 200-day moving average of Benitec Biopharma Inc.?

Benitec Biopharma Inc. 200-day moving average is $11.66.

Who is Benitec Biopharma Inc. CEO?

The CEO of Benitec Biopharma Inc. is -.

How many employees Benitec Biopharma Inc. has?

Benitec Biopharma Inc. has 24 employees.

What is the market cap of Benitec Biopharma Inc.?

The market cap of Benitec Biopharma Inc. is $297M.

What is the P/E of Benitec Biopharma Inc.?

The current P/E of Benitec Biopharma Inc. is null.

What is the EPS of Benitec Biopharma Inc.?

The EPS of Benitec Biopharma Inc. is -$0.98.

What is the PEG Ratio of Benitec Biopharma Inc.?

The PEG Ratio of Benitec Biopharma Inc. is 0.

What do analysts say about Benitec Biopharma Inc.?

According to the analysts Benitec Biopharma Inc. is considered a buy.